ClinicalTrials.gov
ClinicalTrials.gov Menu

The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00292877
Recruitment Status : Completed
First Posted : February 16, 2006
Last Update Posted : January 24, 2011
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
St. Joseph's Healthcare Hamilton

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2008
  Actual Study Completion Date : July 2008
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):